Rhythm Pharmaceuticals (RYTM) Share-based Compensation (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Rhythm Pharmaceuticals | 6.00 Bn | 5.66 Bn | 52.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.90% |
| Dec 31, 2025 | 2.42% |
| Sep 30, 2025 | 18.45% |
| Jun 30, 2025 | 23.46% |
| Mar 31, 2025 | 21.85% |
| Dec 31, 2024 | -4.05% |
| Sep 30, 2024 | 6.21% |
| Jun 30, 2024 | 33.36% |
| Mar 31, 2024 | -10.46% |
| Dec 31, 2023 | 0.72% |
| Sep 30, 2023 | -3.14% |
| Jun 30, 2023 | 39.44% |
| Mar 31, 2023 | 20.60% |
| Dec 31, 2022 | 10.24% |
| Sep 30, 2022 | -6.64% |
| Jun 30, 2022 | 11.41% |
| Mar 31, 2022 | -1.39% |
| Dec 31, 2021 | -11.24% |
| Sep 30, 2021 | -7.07% |
| Jun 30, 2021 | 9.21% |
| Mar 31, 2021 | 21.94% |
| Dec 31, 2020 | -9.33% |
| Sep 30, 2020 | 55.05% |
| Jun 30, 2020 | -44.69% |
| Mar 31, 2020 | 244.54% |
| Dec 31, 2019 | -224.81% |
| Sep 30, 2019 | -7.24% |
| Jun 30, 2019 | 23.75% |
| Mar 31, 2019 | 30.70% |
| Dec 31, 2018 | 6.87% |
| Sep 30, 2018 | 24.87% |
| Jun 30, 2018 | 58.25% |
| Mar 31, 2018 | 35.12% |
| Dec 31, 2017 | -18.60% |
| Sep 30, 2017 | 100.69% |
| Jun 30, 2017 | 64.39% |
| Mar 31, 2017 | -14.56% |